Laczym9000 IU

Laczym is an over-the-counter digestive enzyme supplement used to help digest lactose,the sugar found in milk and dairy products, in people who have lactose intolerance (Laczymdeficiency).

• Established use: Symptomatic relief of bloating, gas, abdominal cramps, anddiarrhea that occur after consuming dairy products in individuals with primary, secondary, orcongenital Laczym deficiency.
• Adjunct use: Laczym is taken together with (not instead of) dairy-containing mealsor snacks; it does not replace a lactose-restricted diet in people with severe intolerance.

Laczym is not indicated for and does not treat:

• Galactosemia - a rare inherited metabolic disorder requiring complete, strictavoidance of galactose. Laczym breaks lactose down into glucose and galactose, so it does not makedairy safe for a person with galactosemia (see Contraindications).
• Milk protein allergy - an immune reaction to milk proteins, a completelydifferent condition from lactose intolerance. Laczym has no effect on allergic reactions to milkproteins.

Each dose of Lactase contains the enzyme lactase (beta-galactosidase),commonly derived from food-grade fungal or yeast sources such as Aspergillus oryzae orKluyveromyces lactis. It is formulated as chewable tablets, capsules, or liquid drops,depending on the brand and product line.

Laczym is the enzyme normally produced by cells lining the small intestine thatbreaks down lactose (milk sugar) into two simpler sugars, glucose and galactose, which can then beabsorbed into the bloodstream. People whose bodies do not make enough of this enzyme developlactose intolerance and experience digestive symptoms after eating dairy.

Laczym supplements provide this enzyme in oral form so it can act on lactose in food duringdigestion, reducing the symptoms that would otherwise occur.

Digestive enzyme supplement (enzyme replacement) - Laczym (beta-galactosidase)

Mechanism of Action

Lactase works locally within the gastrointestinal tract by hydrolyzing (breaking down)lactose into glucose and galactose, mimicking the action of the natural intestinal lactase enzyme.This allows the sugar to be absorbed normally instead of passing undigested into the colon, whereit would otherwise be fermented by bacteria and cause gas, bloating, and diarrhea.

Pharmacokinetics

Lactase acts within the lumen of the gut and is not designed to be, nor is it significantly, absorbedinto the systemic circulation. Because of this local mode of action, it has minimal systemicpharmacokinetic activity (absorption, distribution, metabolism, excretion) of pharmacologicalconcern.

Laczym should be taken orally, right before or with the first mouthful of milk,dairy food, or any lactose-containing product - not after symptoms have already started. Chewabletablets should be chewed, not swallowed whole; liquid drops are mixed into milk or formula shortlybefore feeding, and the mixture should typically be refrigerated for a short period (per productinstructions) to allow the enzyme to begin acting before drinking.

Because Laczym acts locally in the gastrointestinal tract and is not meaningfullyabsorbed into the bloodstream, no clinically significant systemic drug interactions have beenwell-established for Laczym.

As a general precaution, if a product formulation of Laczym is combined with other oral medicines orsupplements, taking them a short time apart is a reasonable precaution, though no specificinteraction of clinical concern is documented.

Laczym is generally very well tolerated, since it acts locally in the gut and is notabsorbed systemically.

• Mild, self-limiting gastrointestinal discomfort (rare).
• Rare hypersensitivity/allergic reactions (e.g., skin rash, itching) in individuals sensitive tothe fungal/yeast source material used to manufacture the enzyme.

Serious side effects are rare given the minimal systemic absorption of Laczym.

Laczym acts locally within the gut and is not significantly absorbed into thebloodstream, so it is generally not expected to reach the fetus or be excreted into breast milk inpharmacologically relevant amounts. However, as with any medicine or supplement, Laczym should be usedduring pregnancy and breastfeeding only if clearly needed, and a physician or pharmacist should beconsulted before use, since formal controlled studies specifically evaluating Laczym in pregnant orbreastfeeding women are limited.

• Laczym does not treat galactosemia and must not be used to make dairy products "safe" for a personwith galactosemia (see Contraindications).
• Laczym does not treat milk protein allergy; it has no effect on the immune reaction to milkproteins and should not be relied upon by individuals with a diagnosed milk protein allergy toprevent allergic reactions.
• The dose of Laczym should be adjusted based on the amount and fat content of the dairy consumed andon individual tolerance - larger or richer dairy meals generally require a higher dose taken at thestart of the meal.
• People with a known allergy to molds or yeast-derived products should check the specific sourceorganism of the enzyme in their Laczym product before use.

Laczym has a wide margin of safety because it acts locally in the digestive tract and is notsignificantly absorbed. Taking more than the recommended dose is unlikely to cause serious harm, butmay cause mild gastrointestinal upset. If a large amount of Laczym is accidentally ingested, especiallyby a young child, or if any concerning symptoms develop, seek prompt medical advice or contact apoison control center/emergency services rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children. Liquid drop formulations may require refrigeration after opening - check the specific product label.

• Elderly: No special dose adjustment of Laczym is required; lactose intolerancebecomes more common with age and Laczym can be used as in other adults.
• Renal/Hepatic impairment: No dose adjustment needed, as Laczym is not systemicallyabsorbed or metabolized by the liver or kidneys (see Pharmacology).
• Infants: Liquid drop formulations of Laczym are used off-label in some infants withsuspected lactose intolerance, generally under a physician's guidance and per product-specificdosing instructions; formal pediatric drug-labeling studies are limited since Laczym is marketed as adietary/enzyme supplement rather than a prescription drug.

Laczym is not taken as a fixed "course" of treatment. It is used on an as-needed basis, each time adairy-containing meal or snack is eaten, for as long as the individual continues to have lactoseintolerance - which, for most people with primary (age-related) Laczym deficiency, is typicallylifelong.

Digestive enzymes; Enzyme replacement/supplement products

Lactase (beta-galactosidase) catalyzes the hydrolysis of the disaccharide lactose intoits two constituent monosaccharides, glucose and galactose, within the lumen of the small intestine.This mimics the action of the endogenous brush-border enzyme that is deficient or absent in peoplewith lactose intolerance, allowing the resulting simple sugars to be absorbed normally andpreventing undigested lactose from reaching the colon, where bacterial fermentation would otherwiseproduce the gas, bloating, cramping, and diarrhea typical of lactose intolerance.

Laczym is commonly used in children able to chew tablets (generally from around 4 years of age,per product labeling) using the same principle as in adults - taken with the first bite of adairy-containing food. Liquid drop formulations of Laczym are also used off-label in infants andyounger children, typically under a physician's or pharmacist's guidance, following product-specificdosing instructions.

Formal safety and efficacy data from controlled pediatric drug trials are limited, as Laczym isgenerally marketed and regulated as a dietary/enzyme supplement rather than a prescriptionmedicine; use in very young infants should be discussed with a pediatrician first.